Human Wild-Type α-Synuclein Drives Progressive Tau Pathology in a Disease-Relevant Mouse Model of Synucleinopathy
The Curious Case of a Heterozygous Loss-of-Function PSEN1 variant associated with Early-Onset Alzheimer’s Disease
Metabolomic and Lipid Alterations are Associated with Longitudinal Neurological Performance in Multiple Sclerosis
Genetics of PLCG2 expression and splicing relative to Alzheimer’s disease risk
Glial-specific and inducible full body C3 deficiency does not affect amyloid pathology in the AppNL-G-F mouse model of Alzheimer’s disease
Learn more about Molecular Neurodegeneration Advances